Assessing the utility of a prognostication model to predict 1-year mortality in patients receiving radiation therapy for spinal metastases

Predicting survival outcomes after radiation therapy alone for metastatic disease of the spine is a challenging task that is important to guiding treatment decisions (e.g., determining dose fractionation and intensity). The New England Spinal Metastasis Score (NESMS) was recently introduced and validated in independent cohorts as a tool to predict 1-year survival following surgery for spinal metastases. This metric is composed of 3 factors: pre-operative albumin, ambulatory status, and modified Bauer score, with the total score ranging from 0 to 3.

from Sports Medicine via xlomafota13 on Inoreader http://ift.tt/2kLpWDj
via IFTTT